Emerging role of epigenetics and miRNA in diabetic cardiomyopathy

Cardiovascular Pathology

Volumn 22, Issue 2, 2013, Pages 117-125

  Asrih, Mohamed ^a   Steffens, Sabine ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Cardiomyopathy; Diabetes; Epigenetics

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; ELASTIN; EXPORTIN 5; FATTY ACID; GLUCOSE; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 29; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE C; PROTEIN KINASE PIM 1; PROTEIN MCL 1; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RIBONUCLEASE III; RNA POLYMERASE II; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; CELL CYCLE ARREST; CPG ISLAND; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DNA METHYLATION; DOPPLER ECHOCARDIOGRAPHY; DYSLIPIDEMIA; ENZYME ACTIVITY; EPIGENETICS; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE HYPERTROPHY; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SYSTOLIC DYSFUNCTION; UPREGULATION;

DIABETIC CARDIOMYOPATHIES; DNA METHYLATION; DYSLIPIDEMIAS; EPIGENESIS, GENETIC; HISTONES; HUMANS; HYPERGLYCEMIA; MICRORNAS; MODELS, CARDIOVASCULAR; OXIDATIVE STRESS; PROTEIN KINASE C; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84873410231     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2012.07.004     Document Type: Review

References (92)

1. W.B. Kannel, M. Hjortland, and W.P. Castelli Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34 1974 29 34
2. S. Rubler, J. Dlugash, Y.Z. Yuceoglu, T. Kumral, A.W. Branwood, and A. Grishman New type of cardiomyopathy associated with diabetic glomerulosclerosis Am J Cardiol 30 1972 595 602
3. J.O. Mudd, and D.A. Kass Tackling heart failure in the twenty-first century Nature 451 2008 919 928
4. Y. Lee, M. Kim, J. Han, K.H. Yeom, S. Lee, and S.H. Baek MicroRNA genes are transcribed by RNA polymerase II EMBO J 23 2004 4051 4060
5. G.W. Dorn, and S.J. Matkovich Put your chips on transcriptomics Circulation 118 2008 216 218
6. B. Khraiwesh, M.A. Arif, G.I. Seumel, S. Ossowski, D. Weigel, and R. Reski Transcriptional control of gene expression by microRNAs Cell 140 2010 111 122
7. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
8. I. Mateo Leach, P. van der Harst, and R.A. de Boer Pharmacoepigenetics in heart failure Curr Heart Fail Rep 7 2010 83 90
9. R.C. Lee, R.L. Feinbaum, and V. Ambros The C elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
10. V. Ambros microRNAs: tiny regulators with great potential Cell 107 2001 823 826
11. N. Bushati, and S.M. Cohen microRNA functions Annu Rev Cell Dev Biol 23 2007 175 205
12. T.W. Nilsen Mechanisms of microRNA-mediated gene regulation in animal cells Trends Genet 23 2007 243 249
13. R.S. Pillai, S.N. Bhattacharyya, and W. Filipowicz Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17 2007 118 126
14. B. Feng, S. Chen, B. George, Q. Feng, and S. Chakrabarti miR133a regulates cardiomyocyte hypertrophy in diabetes Diabetes Metab Res Rev 26 2010 40 49
15. R. Kartha, and S. Subramanian MicroRNAs in cardiovascular diseases: biology and potential clinical applications J Cardiovasc Transl Res 3 2009 256 270
16. B. Feng, S. Chen, J. Chiu, B. George, and S. Chakrabarti Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level Am J Physiol Endocrinol Metab 294 2008 E1119 E1126
17. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431
18. J. Wang, Y. Song, Q. Wang, P.M. Kralik, and P.N. Epstein Causes and characteristics of diabetic cardiomyopathy Rev Diabet Stud 3 2006 108 117
19. Z.Y. Fang, J.B. Prins, and T.H. Marwick Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Endocr Rev 25 2004 543 567
20. X. Han, J. Yang, K. Yang, Z. Zhao, D.R. Abendschein, and R.W. Gross Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study Biochemistry 46 2007 6417 6428
21. T.D. Karamitsos, H.I. Karvounis, E.G. Dalamanga, C.E. Papadopoulos, T.P. Didangellos, and D.T. Karamitsos Early diastolic impairment of diabetic heart: the significance of right ventricle Int J Cardiol 114 2007 218 223
22. B.A. Brooks, B. Franjic, C.R. Ban, K. Swaraj, D.K. Yue, and D.S. Celermajer Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes Diabetes Obes Metab 10 2008 739 746
23. M.K. Poulsen, J.E. Henriksen, J. Dahl, A. Johansen, O. Gerke, and W. Vach Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease Circ Cardiovasc Imaging 3 2010 24 31
24. S.K. Rajan, and S.M. Gokhale Cardiovascular function in patients with insulin-dependent diabetes mellitus: a study using noninvasive methods Ann N Y Acad Sci 958 2002 425 430
25. B. Shivalkar, D. Dhondt, I. Goovaerts, L. Van Gaal, J. Bartunek, and P. Van Crombrugge Flow mediated dilatation and cardiac function in type 1 diabetes mellitus Am J Cardiol 97 2006 77 82
26. Z.Y. Fang, S. Yuda, V. Anderson, L. Short, C. Case, and T.H. Marwick Echocardiographic detection of early diabetic myocardial disease J Am Coll Cardiol 41 2003 611 617
27. J.C. Mbanya, E. Sobngwi, D.S. Mbanya, and K.B. Ngu Left ventricular mass and systolic function in African diabetic patients: association with microalbuminuria Diabetes Metab 27 2001 378 382
28. A. Vered, A. Battler, P. Segal, D. Liberman, Y. Yerushalmi, and M. Berezin Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy) Am J Cardiol 54 1984 633 637
29. A.M. Nugent, I.C. Steele, F. al-Modaris, S. Vallely, A. Moore, and N.P. Campbell Exercise responses in patients with IDDM Diabetes Care 20 1997 1814 1821
30. N. Ozasa, Y. Furukawa, T. Morimoto, E. Tadamura, T. Kita, and T. Kimura Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes Hypertens Res 31 2008 425 432
31. J.W. Ha, H.C. Lee, E.S. Kang, C.M. Ahn, J.M. Kim, and J.A. Ahn Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography Heart 93 2007 1571 1576
32. S.A. Hayat, B. Patel, R.S. Khattar, and R.A. Malik Diabetic cardiomyopathy: mechanisms, diagnosis and treatment Clin Sci (Lond) 107 2004 539 557
33. M. Galderisi, K.M. Anderson, P.W. Wilson, and D. Levy Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study) Am J Cardiol 68 1991 85 89
34. I. Falcao-Pires, and A.F. Leite-Moreira Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment Heart Fail Rev 2011
35. J.M. Huss, and D.P. Kelly Mitochondrial energy metabolism in heart failure: a question of balance J Clin Invest 115 2005 547 555
36. P. Herrero, L.R. Peterson, J.B. McGill, S. Matthew, D. Lesniak, and C. Dence Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus J Am Coll Cardiol 47 2006 598 604
37. B.N. Finck, X. Han, M. Courtois, F. Aimond, J.M. Nerbonne, and A. Kovacs A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content Proc Natl Acad Sci USA 100 2003 1226 1231
38. S. Boudina, and E.D. Abel Diabetic cardiomyopathy revisited. Circulation 115 2007 3213 3223
39. M.E. Young, P. McNulty, and H. Taegtmeyer Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms Circulation 105 2002 1861 1870
40. A. Rodriguez, A. Duran, M. Selloum, M.F. Champy, F.J. Diez-Guerra, and J.M. Flores Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62 Cell Metab 3 2006 211 222
41. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med 329 1993 977 986
42. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
43. D. Susic, J. Varagic, J. Ahn, and E.D. Frohlich Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension Curr Drug Targets Cardiovasc Haematol Disord 4 2004 97 101
44. G.R. Norton, G. Candy, and A.J. Woodiwiss Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats Circulation 93 1996 1905 1912
45. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605
46. R. Petrova, Y. Yamamoto, K. Muraki, H. Yonekura, S. Sakurai, and T. Watanabe Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes J Mol Cell Cardiol 34 2002 1425 1431
47. W.D. Gao, Y. Liu, and E. Marban Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium Circulation 94 1996 2597 2604
48. S. Boudina, and E.D. Abel Diabetic cardiomyopathy, causes and effects Rev Endocr Metab Disord 11 2010 31 39
49. L. Cai, Y. Wang, G. Zhou, T. Chen, Y. Song, and X. Li Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy J Am Coll Cardiol 48 2006 1688 1697
50. X. Shen, S. Zheng, N.S. Metreveli, and P.N. Epstein Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy Diabetes 55 2006 798 805
51. V. Jaquet, L. Scapozza, R.A. Clark, K.H. Krause, and J.D. Lambeth Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets Antioxid Redox Signal 11 2009 2535 2552
52. P. Xia, T. Inoguchi, T.S. Kern, R.L. Engerman, P.J. Oates, and G.L. King Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia Diabetes 43 1994 1122 1129
53. J.C. Braz, K. Gregory, A. Pathak, W. Zhao, B. Sahin, and R. Klevitsky PKC-alpha regulates cardiac contractility and propensity toward heart failure Nat Med 10 2004 248 254
54. A. Koj Initiation of acute phase response and synthesis of cytokines Biochim Biophys Acta 1317 1996 84 94
55. M.B. Given, R.F. Lowe, C.R. Gelvin, G.E. Sander, and T.D. Giles Preservation of left ventricular function and coronary flow by angiotensin I-converting enzyme inhibition in the hypertensive-diabetic Dahl rat Am J Hypertens 7 1994 919 925
56. D.D. Belke, and W.H. Dillmann Altered cardiac calcium handling in diabetes Curr Hypertens Rep 6 2004 424 429
57. G.N. Pierce, and J.C. Russell Regulation of intracellular Ca2+ in the heart during diabetes Cardiovasc Res 34 1997 41 47
58. M. Biel, V. Wascholowski, and A. Giannis Epigenetics - an epicenter of gene regulation: histones and histone-modifying enzymes Angew Chem Int Ed Engl 44 2005 3186 3216
59. A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P.L. Jones, and R.G. Roeder Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia J Exp Med 205 2008 2409 2417
60. D. Brasacchio, J. Okabe, C. Tikellis, A. Balcerczyk, P. George, and E.K. Baker Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail Diabetes 58 2009 1229 1236
61. F. Miao, D.D. Smith, L. Zhang, A. Min, W. Feng, and R. Natarajan Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes Diabetes 57 2008 3189 3198
62. A.B. Gaikwad, S.G. Sayyed, J. Lichtnekert, K. Tikoo, and H.J. Anders Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes Am J Pathol 176 2010 1079 1083
63. S. Chang, T.A. McKinsey, C.L. Zhang, J.A. Richardson, J.A. Hill, and E.N. Olson Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development Mol Cell Biol 24 2004 8467 8476
64. Y. Hamamori, and M.D. Schneider HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy J Clin Invest 112 2003 824 826
65. D.S. Schrump Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications Clin Cancer Res 15 2009 3947 3957
66. X.Y. Yu, Y.J. Geng, Q.X. Lin, H.S. Xia, Z.X. Shan, and M. Yang High glucose leads to increased inflammatory gene expression via epigenetic histone H3 lysine 9 methylation in cardiomyocyte Circulation 2010 122
67. M. Movassagh, M.K. Choy, M. Goddard, M.R. Bennett, T.A. Down, and R.S. Foo Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure PLoS One 5 2010 e8564
68. Y.H. Kao, Y.C. Chen, C.C. Cheng, T.I. Lee, Y.J. Chen, and S.A. Chen Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes Crit Care Med 38 2010 217 222
69. H. Monkemann, A.S. De Vriese, H.J. Blom, L.A. Kluijtmans, S.G. Heil, and H.H. Schild Early molecular events in the development of the diabetic cardiomyopathy Amino Acids 23 2002 331 336
70. C.J. Kuan, M. al-Douahji, and S.J. Shankland The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy J Am Soc Nephrol 9 1998 986 993
71. H. Kaneto, Y. Kajimoto, Y. Fujitani, T. Matsuoka, K. Sakamoto, and M. Matsuhisa Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction Diabetologia 42 1999 1093 1097
72. R.W. Carthew, and E.J. Sontheimer Origins and mechanisms of miRNAs and siRNAs Cell 136 2009 642 655
73. V.N. Kim, J. Han, and M.C. Siomi Biogenesis of small RNAs in animals Nat Rev Mol Cell Biol 10 2009 126 139
74. Y.K. Kim, and V.N. Kim Processing of intronic microRNAs EMBO J 26 2007 775 783
75. M. Morlando, M. Ballarino, N. Gromak, F. Pagano, I. Bozzoni, and N.J. Proudfoot Primary microRNA transcripts are processed co-transcriptionally Nat Struct Mol Biol 15 2008 902 909
76. C. Okada, E. Yamashita, S.J. Lee, S. Shibata, J. Katahira, and A. Nakagawa A high-resolution structure of the pre-microRNA nuclear export machinery Science 326 2009 1275 1279
77. J.F. Chen, E.P. Murchison, R. Tang, T.E. Callis, M. Tatsuguchi, and Z. Deng Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure Proc Natl Acad Sci USA 105 2008 2111 2116
78. T. Thum Cardiac dissonance without conductors: how dicer depletion provokes chaos in the heart Circulation 118 2008 1524 1527
79. V.N. Kim MicroRNA biogenesis: coordinated cropping and dicing Nat Rev Mol Cell Biol 6 2005 376 385
80. Y. Cheng, R. Ji, J. Yue, J. Yang, X. Liu, and H. Chen MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170 2007 1831 1840
81. J. Brennecke, A. Stark, and S.M. Cohen Not miR-ly muscular: microRNAs and muscle development Genes Dev 19 2005 2261 2264
82. Katare R, Caporali A, Zentilin L, Avolio E, Sala-Newby G, Oikawa A, et al. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res;108:1238-1251.
83. J. Xiao, X. Luo, H. Lin, Y. Zhang, Y. Lu, and N. Wang MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts J Biol Chem 282 2007 12363 12367
84. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009;104:170-178, 176p following 178.
85. M. Fabbri, R. Garzon, A. Cimmino, Z. Liu, N. Zanesi, and E. Callegari MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci USA 104 2007 15805 15810
86. J.L. Mott, S. Kobayashi, S.F. Bronk, and G.J. Gores mir-29 regulates Mcl-1 protein expression and apoptosis Oncogene 26 2007 6133 6140
87. S.G. Gray, and P. De Meyts Role of histone and transcription factor acetylation in diabetes pathogenesis Diabetes Metab Res Rev 21 2005 416 433
88. J.F. Chen, E.M. Mandel, J.M. Thomson, Q. Wu, T.E. Callis, and S.M. Hammond The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nat Genet 38 2006 228 233
89. T. Babak, W. Zhang, Q. Morris, B.J. Blencowe, and T.R. Hughes Probing microRNAs with microarrays: tissue specificity and functional inference RNA 10 2004 1813 1819
90. C.G. Liu, G.A. Calin, B. Meloon, N. Gamliel, C. Sevignani, and M. Ferracin An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues Proc Natl Acad Sci USA 101 2004 9740 9744
91. Y. Zhao, E. Samal, and D. Srivastava Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis Nature 436 2005 214 220
92. Y. Saito, G. Liang, G. Egger, J.M. Friedman, J.C. Chuang, and G.A. Coetzee Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell 9 2006 435 443